ProKidney Appoints Kenneth Locke as Chief Technical Officer
ProKidney appointed Kenneth Locke as Chief Technical Officer to lead technical strategy and manufacturing operations. Locke brings extensive experience from Carisma Therapeutics, Celgene, and Novartis, specifically in scaling cell therapy platforms and managing CMC functions.
Key figures
- Cash runway
- mid-2027
- Pivotal readout timing
- Q2 2027
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.